LoginRegister
    Wize Pharma Completes Patient Enrollment In Phase IV Study Of LO2A for the Treatment of Dry Eye Syndrome in Patients With Sjögrens SyndromeWize Pharma Completes Patient Enrollment In Phase IV Study Of LO2A for the Treatment of Dry Eye...
    FDA warns about potential cybersecurity vulnerabilities for certain GE Healthcare Clinical Information Central Stations and Telemetry ServersFDA warns about potential cybersecurity vulnerabilities for certain GE Healthcare Clinical...
    Indian American Pharma millionaire sent to 5.5 years imprisonment for bribery for pushing opioidsIndian American Pharma millionaire sent to 5.5 years imprisonment for bribery for pushing opioids
    Cipla gets USFDA observations for its Goa facilityCipla gets USFDA observations for its Goa facility
    Alembic Pharma gets final USFDA nod for Fenofibrate tabletsAlembic Pharma gets final USFDA nod for Fenofibrate tablets
    Medicine shops remain shut across Bihar as pharmacist oppose new regulationMedicine shops remain shut across Bihar as pharmacist oppose new regulation
    Piramal Group to infuse Rs 500 crore in pharma operations in TelanganaPiramal Group to infuse Rs 500 crore in pharma operations in Telangana
    Japanese financial group MUFG sells 2.10pc shares in CiplaJapanese financial group MUFG sells 2.10pc shares in Cipla
    Lupin Foundation Wins IDMA Corporate Citizen Award 2019Lupin Foundation Wins IDMA Corporate Citizen Award 2019
    Biocon Biologics gets Rs 536 crore investment from True North FundBiocon Biologics gets Rs 536 crore investment from True North Fund
    GE South Asia gets Mahesh Palashikar as new President, CEOGE South Asia gets Mahesh Palashikar as new President, CEO
    Lupin concludes third edition of medical symposiums for Indian urology communityLupin concludes third edition of medical symposiums for Indian urology community
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X